e-Newsletter October 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Search
Search results
Our staff
We employ a number of full and part-time staff. Our office is in Buckingham.
Webinar: Michael Gilhooley, Optogenetics
This session will introduce the technique of optogenetics and its potential for development into a treatment for IRDs.
Webinar: Medical images and what they show
Dr Daniel Jackson discusses what images you are likely to have during a hospital appointment; how they are taken; why we take them; how we interpret them; and how this helps in the management and treatment of retinal conditions
Meet our Trustee: Dr Elizabeth Graham FRCP FRCOphth
Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.
Meet our Trustee: Vanessa Forster
Vanessa is the General Counsel at the Alan Turing Institute, the UK’s national data science and artificial intelligence research institute.
RECORDING: Professionals’ Conference – 8 July 2022
A recording of the Retina UK Professionals' Conference on 8 July 2022. The Conference was held at the Macdonald Burlington Hotel in Birmingham and also online.
e-Newsletter – January 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Children and young people
Different inherited sight loss conditions present noticeable symptoms at different times.
ProQR announces suspension of LCA10 and USH2A clinical trials
Biotechnology company ProQR has announced that its clinical trials of sepofarsen for Leber congenital amaurosis type 10 and ultevursen for USH2A-mediated retinitis pigmentosa will be wound down with immediate effect.